Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population

被引:5
作者
Mishra, A. [1 ]
Agrawal, V [2 ]
Krishnani, N. [2 ]
Mishra, S. K. [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine Surg, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pathol, Lucknow 226014, Uttar Pradesh, India
关键词
DTC; oncogene; rearranged during transfection protein; ONCOGENE ACTIVATION; PROTEIN EXPRESSION; GENE REARRANGEMENTS; RET; TUMORS; CHILDREN; LESIONS; SEARCH; CANCER;
D O I
10.4103/0022-3859.57390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The prevalence of Rearranged during Transfection/ Papillary Thyroid Carcinoma (RET/PTC) rearrangement in papillary thyroid carcinoma (PTC) varies in different geographic regions and its prognostic significance remains unclear. Aim: The aim of this study was to recognize the prevalence of RET/PTC expression in PTC from the endemically iodine-deficient region in Northern India and to correlate the expression with the clinicopathologic prognostic factors. Settings and Design: Retrospective. Archival tissue used. Materials and Methods: Immunohistochemistry was performed to look for activated RET protein expression in 50 cases of PTC. No patient had any history of prior irradiation. Statistical Analysis Used: Chi-square method, Student t test, and binary regression method. A P value of <.05 was considered significant for all the tests. Results: The prevalence of RET expression was 44%. Twenty-six (52%) cases showed RET immunoreactivity in histiocytes. Immunoreactivity was the highest in the classic variant of PTC (47.5%), followed by tumors with poorly differentiated areas (25%) and follicular variant (16.7%). RET expression was more prevalent in young patients (45.5 vs. 35.3%), females (43.3 vs. 40.0%), small tumors (33.3 vs. 26.7%), multicentric tumors (36.8 vs. 33.3%), tumors with extrathyroidal invasion (38.9 vs. 32.4%), and regional lymphadenopathy (55.2 vs. 22.2%), while it was less in cases with distant metastases (20 vs. 43.9%). There was no significant correlation of immunoreactivity with any prognostic factor. However, when the cases having immunoreactivity within histiocytes (n = 26) and histiocytes + tumor tissue (n = 28) were considered, then the expression was significantly more in cases with lymphadenopathy (P values =.009, in both instances). However, the exact clinical significance of RET/PTC positive histiocytes remained unexplained. Conclusions: Prevalence of RET/PTC in our study was consistent with the reported prevalence from other geographic areas. There was no significant correlation with the clinicopathologic factors. However, uniform techniques of detection and large international collaborative studies could clear the uncertainties regarding the prognostic importance of RET/PTC.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 31 条
[1]   RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma [J].
Basolo, F ;
Molinaro, E ;
Agate, L ;
Pinchera, A ;
Pollina, L ;
Chiappetta, G ;
Monaco, C ;
Santoro, M ;
Fusco, A ;
Miccoli, P ;
Elisei, R ;
Capezzone, M ;
Pacini, F .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (05) :599-604
[2]   Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene [J].
Borrello, MG ;
Alberti, L ;
Fischer, A ;
Degl'Innocenti, D ;
Ferrario, C ;
Gariboldi, M ;
Marchesi, F ;
Allavena, P ;
Greco, A ;
Collini, P ;
Pilotti, S ;
Cassinelli, G ;
Bressan, P ;
Fugazzola, L ;
Mantovani, A ;
Pierotti, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (41) :14825-14830
[3]   Different significance of ret/PTC1 and ret/PTC3 rearrangements in thyroid carcinogenesis:: Lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation [J].
Cetta, F ;
Gori, M ;
Montalto, G ;
Zuckermann, M ;
Toti, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1429-1429
[4]   The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions [J].
Chiappetta, G ;
Toti, P ;
Cetta, F ;
Giuliano, A ;
Pentimalli, F ;
Amendola, I ;
Lazzi, S ;
Monaco, M ;
Mazzuchelli, L ;
Tosi, P ;
Santoro, M ;
Fusco, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :364-369
[5]   RET oncogene expression of papillary thyroid carcinoma in Korea [J].
Chung, KW ;
Chang, MC ;
Noh, DY ;
Oh, SK ;
Choe, KJ ;
Youn, YK .
SURGERY TODAY, 2004, 34 (06) :485-492
[6]   RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions [J].
Collins, BJ ;
Chiappetta, G ;
Schneider, AB ;
Santoro, M ;
Pentimalli, F ;
Fogelfeld, L ;
Gierlowski, T ;
Shore-Freedman, E ;
Jaffe, G ;
Fusco, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3941-3946
[7]   Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure [J].
Fischer, AH ;
Bond, JA ;
Taysavang, P ;
Battles, OE ;
Wynford-Thomas, D .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (05) :1443-1450
[8]   Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma - A search for the early precursors of papillary cancer [J].
Fusco, A ;
Chiappetta, G ;
Hui, P ;
Garcia-Rostan, G ;
Golden, L ;
Kinder, BK ;
Dillon, DA ;
Giuliano, A ;
Cirafici, AM ;
Santoro, M ;
Rosai, J ;
Tallini, G .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (06) :2157-2167
[9]   Expression of RET in follicular cell-derived tumors of the thyroid gland: Prevalence and implication of morphological type [J].
Inaba, M ;
Umemura, S ;
Satoh, H ;
Abe, Y ;
Kurokawa, K ;
Sakai, H ;
Osamura, RY .
PATHOLOGY INTERNATIONAL, 2003, 53 (03) :146-153
[10]  
Klugbauer S, 1995, ONCOGENE, V11, P2459